Amylyx Pharmaceuticals Inc.
03/26/2025 | Press release | Distributed by Public on 03/27/2025 04:02
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
|
|||||||